Key Highlights: Implications: The USFDA’s EIR and VAI classification provide regulatory closure for Strides Pharma’s Bengaluru facility following the five observations issued during the May 2026 inspe...
Latest Developments in USFDA Inspections India plays a crucial role in the global pharmaceutical supply chain, supplying a large share of generic medicines to markets around the world. As Indian...
Relevant Global and Market Data India’s biopharmaceutical export story is one of remarkable transformation. From being a net importer of medicines in the late 20th century to becoming the “...
